文献速递生殖医学

无检查药物流产:一项系统综述

No-Test Medication Abortion: A Systematic Review.
PubMed 文献 · Obstet Gynecol · 2022-12-05

该系统综述检索多个数据库至2022年4月,纳入21项研究共10,693例患者,评估无盆腔检查或超声即行米非司酮联合米索前列醇药物流产的有效性与安全性。总体有效率为96.4%,孕63天内为93.8%(95%CI 92.8-94.6%),孕70天内为95.2%(95%CI 94.7-95.7%)。结论认为无检查药物流产是安全有效的终止妊娠选择。

要点

  • 无检查药物流产总体有效率为96.4%。
  • 孕63天内有效率93.8%,孕70天内有效率95.2%。
  • 需手术清宫率4.4%,需额外米索前列醇2.2%,输血0.5%,异位妊娠0.06%。

核心结论

  • 无盆腔检查或超声即行药物流产是安全有效的终止妊娠选择。

研究设计与样本

  • 系统综述,检索MEDLINE、Scopus、Web of Science、Cochrane(含ClinicalTrials.gov)、CINAHL、Global Index Medicus和CAB Direct数据库至2022年4月,并联系专家获取未发表数据及进行中研究。
  • 共筛选2,423项研究,最终纳入21项研究,合计10,693例有结局数据的患者。
  • 纳入标准为报告米非司酮联合米索前列醇且无盆腔检查或超声的药物流产临床结局;排除数据重复的研究。

主要发现

  • 无检查药物流产总体有效率为96.4%。
  • 孕63天内有效率为93.8%(95%CI 92.8-94.6%)。
  • 孕70天内有效率为95.2%(95%CI 94.7-95.7%)。
  • 总体手术清宫率为4.4%(95%CI 4.0-4.9)。
  • 需额外米索前列醇率为2.2%(95%CI 1.8-2.6),输血率为0.5%(95%CI 0.3-0.6),异位妊娠率为0.06%(95%CI 0.02-0.15)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To summarize the effectiveness and safety outcomes of medication abortion performed without prior pelvic examination or ultrasonogram ("no-test medication abortion"). DATA SOURCES: We searched the MEDLINE, Scopus, Web of Science, Cochrane (including ClinicalTrials.gov), CINAHL, Global Index Medicus, and CAB Direct databases to identify relevant studies published before April 2022 using a peer-reviewed search strategy including terms such as "medication abortion" and "ultrasonography." We contacted experts in the field for unpublished data and ongoing studies. METHODS OF STUDY SELECTION: We reviewed 2,423 studies using Colandr. We included studies if they presented clinical outcomes of medication abortion performed with mifepristone and misoprostol and without prior pelvic examination or ultrasonogram. We excluded studies with duplicate data. We abstracted successful abortion rates overall, as well as rates by gestational age through 63 days, 70 days and past 84 days. We abstracted complication rates, including the need for surgical evacuation, additional medications, blood transfusion, and ectopic pregnancy. TABULATION, INTEGRATION AND RESULTS: We included 21 studies with a total of 10,693 patients with outcome data reported. The overall efficacy of no-test medication abortion was 96.4%; 93.8% (95% CI 92.8-94.6%) through 63 days of gestation and 95.2% (95% CI 94.7-95.7%) through 70 days of gestation. The overall rate of surgical evacuation was 4.4% (95% CI 4.0-4.9), need for additional misoprostol 2.2% (95% CI 1.8-2.6), blood transfusion 0.5% (95% CI 0.3-0.6), and ectopic pregnancy 0.06% (95% CI 0.02-0.15). CONCLUSION: Medication abortion performed without prior pelvic examination or ultrasonogram is a safe and effective option for pregnancy termination. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021240739.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pearlman Shapiro M, Dethier D, Kahili-Heede M, et al. No-Test Medication Abortion: A Systematic Review. Obstet Gynecol. 2022. PMID: 36701607. doi:10.1097/AOG.0000000000005016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。